China Keytruda Market: How Is Patient Assistance Programs Bridging...

added blog Haber

2026-05-19 05:08:36

China Keytruda Market: How Is Patient Assistance Programs Bridging the Reimbursement Gap?

Patient assistance and access programs for pembrolizumab — the MSD China initiatives bridging the access gap between NRDL-covered indications and out-of-pocket cost for non-covered indications — creates an important commercial market dimension, with the China Keytruda Market reflecting access programs as both humanitarian and commercial strategy enabling patient access while...

0 Comments 0 Shares 9 Views 0 Reviews